Back to CVE records
High 8.8Published Oct 23, 2026

CVE-2026-56832PraisonAI DiscordApproval accepts unrelated channel messages as dangerous-tool approvals

Updated under an hour ago ()

Does this affect you?

It affects MervinPraison PraisonAI. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.15%, higher than 4% of scored CVEs.

PraisonAI is a multi-agent teams system. From version 4.5.2 to before version 4.6.59, praisonai.bots.DiscordApproval approves a pending dangerous tool call when it sees any later non-bot message in the configured Discord channel whose text is classified as approval, such as yes. As a result, any user who can post in the configured approval channel can approve a pending high-risk tool call by sending yes after the approval message appears. the same PoV also shows that the Slack and Telegram messaging approval backends have no explicit approver allowlist parameter, but the primary report-grade issue is the Discord backend's unthreaded channel cross-talk: the approving message does not need to be a reply or otherwise request-bound. This issue has been patched in version 4.6.59.

CVSS
8.8 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness (CWE)
CWE-345, CWE-863
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.15% (percentile 4)
Assigned by
GitHub_M
NVD analysis
Deferred
Record last updated
Oct 23, 2026
First seen by InfoSec Signals
Oct 23, 2026

Affected products

Affected products
MervinPraison PraisonAI
mervinpraison:praisonai (from the name)
from 4.5.2, < 4.6.59
CNA record

References

References

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.